Biomarin Pharmaceutical Inc (BMRN) Insider Trading

Total insider buys:
  • $1,316,196.75
Total insider sells:
  • $342,139,664.94
Most recent insider trade:
  • Nov. 12, 2024
Most active insider trader:
  • Jean Jacques Bienaime
Trader NameDateTitleAmountPriceTypeTotal Value
May 4, 2022CFO11,800$84.50Sell$997,100.00
May 2, 2022EVP15,347$80.38Sell$1,233,591.86
May 2, 2022Director3,878$82.09Sell$318,345.02
April 28, 2022CEO20,000$83.79Sell$1,675,800.00
April 18, 2022CEO20,000$81.91Sell$1,638,200.00
April 14, 2022Director4,250$83.66Sell$355,555.00
April 14, 2022CEO10,000$83.66Sell$836,600.00
April 13, 2022EVP1,180$82.47Sell$97,314.60
March 29, 2022EVP1,618$79.43Sell$128,517.74
March 23, 2022EVP6,129$81.78Sell$501,229.62
March 21, 2022EVP6,129$81.29Sell$498,226.41
March 10, 2022CEO15,000$77.57Sell$1,163,550.00
Feb. 28, 2022Director6,396$78.33Sell$500,998.68
Jan. 14, 2022Director4,250$87.61Sell$372,342.50
Jan. 13, 2022CEO5,000$87.86Sell$439,300.00
Dec. 15, 2021CEO6,000$82.71Sell$496,260.00
Dec. 1, 2021CEO1,500$87.22Sell$130,830.00
Oct. 26, 2021EVP2,739$73.60Sell$201,590.40
May 10, 2021CEO8,513$77.29Sell$657,969.77
May 7, 2021CFO6,709$79.50Sell$533,365.50
May 7, 2021CEO25,000$78.12Sell$1,953,000.00
May 6, 2021Director5,068$78.38Sell$397,229.84
May 3, 2021EVP4,673$78.30Sell$365,895.90
April 23, 2021CEO10,000$79.34Sell$793,400.00
April 19, 2021EVP2,709$79.58Sell$215,582.22
April 8, 2021EVP1,537$78.81Sell$121,130.97
April 1, 2021CFO5,692$76.30Sell$434,299.60
March 24, 2021EVP1,181$76.30Sell$90,110.30
March 18, 2021EVP1,308$77.99Sell$102,010.92
March 11, 2021CEO7,000$77.68Sell$543,760.00
March 5, 2021Director5,000$76.28Sell$381,400.00
Feb. 19, 2021CEO7,000$83.58Sell$585,060.00
Feb. 17, 2021CEO8,000$84.54Sell$676,320.00
Jan. 29, 2021CEO8,334$82.67Sell$688,971.78
Jan. 27, 2021CEO8,333$85.49Sell$712,388.17
Dec. 28, 2020CEO1,500$88.77Sell$133,155.00
Oct. 14, 2020EVP2,121$79.91Sell$169,489.11
Aug. 31, 2020Director12,800$78.26Buy$1,001,728.00
Aug. 3, 2020Director2,500$120.35Sell$300,875.00
July 20, 2020Insider126,389$130.00Sell$16,430,570.00
July 13, 2020Insider23,011$130.00Sell$2,991,430.00
June 26, 2020Director4,430$123.61Sell$547,592.30
June 19, 2020EVP15,000$124.00Sell$1,860,000.00
June 5, 2020Director4,430$107.46Sell$476,047.80
May 8, 2020CEO20,000$91.72Sell$1,834,400.00
May 4, 2020CEO5,000$88.00Sell$440,000.00
May 1, 2020EVP12,504$89.38Sell$1,117,607.52
May 1, 2020CEO4,000$89.38Sell$357,520.00
April 28, 2020CEO20,000$97.58Sell$1,951,600.00
April 24, 2020Insider20,000$95.88Sell$1,917,600.00
  • Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.

  • The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere

  • The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.

  • Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.

  • David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.

  • The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.

  • The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.

  • The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.